Copyright Clearance Center Hosts Emerging Life Sciences Organizations to Advance Research Innovation at Exclusive Virtual RightFind® Roundtable Event

Invitation-Only Digital Gathering Encouraged Collaboration and Delivered Value to Biotech and R&D-Intensive Customers

DANVERS, Mass.--()--Copyright Clearance Center, Inc. (CCC), a leader in advancing copyright, accelerating knowledge, and powering innovation, recently hosted an invitation-only RightFind Roundtable with a select group of emerging life sciences customers. The two-day virtual event was comprised of a series of in-depth discussions about the changing information and data needs unique to these organizations.

RightFind is CCC’s award-winning research solution for hundreds of global R&D teams and other corporate content users from the smallest emerging life sciences company to the largest global R&D organizations in the world. It provides centralized seamless access to high-value content from subscriptions, licenses, and document delivery through intuitive software and services. Named “Best E-Discovery Solution” by KMWorld in its inaugural Readers’ Choice Awards, RightFind is comprised of application modules that integrate seamlessly with CCC’s annual copyright licenses.

“Our emerging life science customers have many of the same needs as more established firms – including getting information into the hands of researchers quickly and removing roadblocks to innovation – but are also uniquely challenged with a lack of dedicated librarians, consistently changing headcount, and limited content management or copyright strategy,” said Lauren Tulloch, Vice President and Managing Director, Corporate Solutions, CCC. “The RightFind Roundtable sessions ensure we remain focused on our customers’ top priorities for content and licensing, especially amidst the global COVID-19 pandemic, and provide a collaborative forum to create high-impact, scalable solutions that help drive innovation for companies of any size.”

Since the early days of the pandemic, CCC has been committed to supporting global research efforts. CCC created a collection in RightFind of open-to-read content covering COVID and related diseases, which currently includes more than 175,000 articles and preprints. The CCC team continues to amplify the work of publishers, data creators, and data aggregators who are contributing to the common good by providing visualizations, dashboards, and access to datasets related to COVID-19.

With 40 years of experience working with content creators and users, CCC has a long history of building efficient solutions to address industry challenges. Led by content workflow experts with experience helping research organizations around the globe, CCC processes data feeds from nearly all major publishing houses and metadata aggregators accounting for more than 140M unique records per year across a wide range of industries. CCC also manages millions of rights and helps to promote collaboration and simplify copyright compliance.

ABOUT COPYRIGHT CLEARANCE CENTER

Copyright Clearance Center (CCC) builds unique solutions that connect content and rights in contextually relevant ways through software and professional services. CCC helps people navigate vast amounts of data to discover actionable insights, enabling them to innovate and make informed decisions. CCC, with its subsidiary RightsDirect, collaborates with customers to advance how data and information is integrated, accessed, and shared while setting the standard for effective copyright solutions that accelerate knowledge and power innovation. CCC is headquartered in Danvers, Mass. with offices across North America, Europe and Asia. To learn more about CCC, visit www.copyright.com.

Contacts

Craig Sender
Senior Director, Public & Analyst Relations
csender@copyright.com
917-626-7152

Release Summary

CCC recently hosted an invitation-only roundtable to discuss the changing information and data needs unique to emerging life sciences organizations.

Contacts

Craig Sender
Senior Director, Public & Analyst Relations
csender@copyright.com
917-626-7152